共 47 条
Hippocampal dysfunction defines disease onset in Huntington's disease
被引:48
作者:
Begeti, Faye
[1
]
Schwab, Laetitia C.
[1
]
Mason, Sarah L.
[1
]
Barker, Roger A.
[1
,2
]
机构:
[1] Univ Cambridge, Dept Clin Neurosci, John van Geest Ctr Brain Repair, Forvie Site,Robinson Way, Cambridge CB2 0PY, England
[2] Addenbrookes Hosp, Dept Neurol, Cambridge, England
关键词:
TRANSGENIC MOUSE MODEL;
SYNAPTIC PLASTICITY;
RECOGNITION MEMORY;
NEUROGENESIS;
NAVIGATION;
IMPAIRMENTS;
RECEPTORS;
COGNITION;
DEMENTIA;
DEFICITS;
D O I:
10.1136/jnnp-2015-312413
中图分类号:
R74 [神经病学与精神病学];
学科分类号:
摘要:
Background Huntington's disease (HD) is an autosomal dominant neurodegenerative disorder characterised by a triad of motor, psychiatric and cognitive deficits with the latter classically attributed to disruption of frontostriatal networks. However, emerging evidence from animal models of HD suggests that some of the early cognitive deficits may have a hippocampal basis. The objective of this study was to link previous rodent findings in this area to clinical practice. Methods In this study, 94 participants included patients with early HD, premanifest HD and age-matched controls underwent hippocampal-based cognitive assessments. These included a virtual reality version of the Morris water maze, a task involved participants having to swim through a virtual pool to find a submerged platform using a joystick, and the Cambridge Neuropsychological Test Automated Battery (CANTAB) paired associates learning task, a test also known to rely on hippocampal integrity. Results Patients with early HD showed impaired performance in both the virtual Morris water maze and the CANTAB paired associates learning. Such deficits were also correlated with estimated years to diagnosis in premanifest participants. Conclusions This study highlights the merit of using analogous tests in the laboratory and clinic and demonstrates that hippocampal impairments are an early feature of HD in patients as previously shown in rodent models of the disease. As such, they could be used not only to assist in the diagnosis of disease onset, but may also be useful as an outcome measure in future therapeutic trials.
引用
收藏
页码:975 / 981
页数:7
相关论文